戻る Agenda
Building Acumen: P-Value Power Learning
Session Chair(s)
Kimberly Belsky, MS
Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States
This power session will build your acumen on understanding p-values and the role of confidence intervals (CIs) and minimum clinically important differences (MCIDs) in interpreting study results and statistical significance. Published scientific conclusions often apply the concept of statistical significance, commonly assessed with p-values. However, in light of common misconceptions concerning p-values, researchers may elect to supplement p-values with other approaches, such as CIs and MCIDs. Alternative approaches also become relevant in the context of large real-world evidence studies.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify issues relating to the concept of statistical significance
- Recognize approaches that supplement p-values
- Examine quantitative study results in context rather than relying on significance tests
Speaker(s)
Speaker
Elaine Böing, MPH
Ipsen Biopharmaceuticals, Inc., United States
Director, Health Economics and Outcomes Research (HEOR), Rare Disease